Literature DB >> 1263082

Dissolution rates of high energy sulfathiazole--povidone coprecipitates II: characterization of form of drug controlling its dissolution rate via solubility studies.

A P Simonelli, S C Mehta, W I Higuchi.   

Abstract

Solubility studies were made to characterize the form of sulfathiazole controlling the rate of dissolution exhibited in previously reported dissolution rate studies of sulfathiazole coprecipitated with povidone. The aqueous solubility of the high energy form of sulfathiazole obtained using sulfathiazole--povidone coprecipitates was determined in the presence of polymer in solution. Its aqueous solubility in the absence of polymer was determined by extrapolation. The solubility value was much greater than either the supercooled melt or the crystalline forms of sulfathiazole. Stabilization of these sulfathiazole solutions supersaturated with respect to the more stable crystalline form was achieved by the addition of sufficient polymer to the solution to prevent nucleation of the crystalline form. The concentration of polymer required to prevent nucleation of the crystalline forms was much higher than the previously reported concentrations required to inhibit crystal growth of sulfathiazole. The ratio of the solubility value obtained for the coprecipitated sulfathiazole as compared with its crystalline form I was in agreement with the ratio of their dissolution rates obtained the plateau regions of the dissolution rate experiments reported previously. The extrapolated aqueous solubility values in the absence of povidone were obtained as a function of temperature and were utilized to obtain thermodynamic parameters. The difference in the heat of solution of the two forms of sulfathiazole from the slope of the van't Hoff plots of the extrapolated solubility values was 1618 cal/mole, in excellent agreement with the literature value. The free energy, enthalpy, and entropy at 27 degrees for the coprecipitated drug relative to its crystalline form I were 1125 cal/mole, 8439 cal/mole, and 24 eu, respectively, indicating the high degree of molecular randomness and lack of structure in these high energy systems. These results provide strong evidence for the presence of an amorphous state of sulfathiazole as the controlling phase of both the solubility and dissolution rate experiments involving the high energy form of sulfathiazole obtained by coprecipitation with povidone.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1263082     DOI: 10.1002/jps.2600650310

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  16 in total

Review 1.  Haste Makes Waste: The Interplay Between Dissolution and Precipitation of Supersaturating Formulations.

Authors:  Dajun D Sun; Ping I Lee
Journal:  AAPS J       Date:  2015-09-03       Impact factor: 4.009

2.  Solubilization and in vitro spermicidal assessment of nonoxynol-9 and selected fractions using rabbit spermatozoa.

Authors:  B A Walter; A A Hawi; P M Zavos; G A Digenis
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

3.  The effects of absorbed water on the properties of amorphous mixtures containing sucrose.

Authors:  S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

4.  Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.

Authors:  Hitesh S Purohit; Lynne S Taylor
Journal:  Pharm Res       Date:  2017-09-27       Impact factor: 4.200

5.  Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.

Authors:  Emad B Basalious; Wessam El-Sebaie; Omaima El-Gazayerly
Journal:  AAPS PharmSciTech       Date:  2011-06-24       Impact factor: 3.246

6.  Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.

Authors:  T Matsumoto; G Zografi
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

7.  Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns.

Authors:  Simon Bates; George Zografi; David Engers; Kenneth Morris; Kieran Crowley; Ann Newman
Journal:  Pharm Res       Date:  2006-09-22       Impact factor: 4.200

8.  Crystallization from Supersaturated Solutions: Role of Lecithin and Composite Simulated Intestinal Fluid.

Authors:  Anura S Indulkar; Yi Gao; Shweta A Raina; Geoff G Z Zhang; Lynne S Taylor
Journal:  Pharm Res       Date:  2018-06-18       Impact factor: 4.200

9.  Dissolution kinetics for coprecipitates of diflunisal with PVP K30.

Authors:  C Rodríguez-Espinosa; M C Martínez-Ohárriz; C Martín; M M Goñi; I Vélaz; M Sánchez
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

10.  Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu.

Authors:  William Curatolo; James A Nightingale; Scott M Herbig
Journal:  Pharm Res       Date:  2009-03-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.